References
- Findlay AR, Goyal NA, Mozaffar T. An overview of polymyositis and dermatomyositis. Muscle Nerve. 2015;51(5):638–656.
- Mammen AL. Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis. Ann NY Acad Sci. 2010;1184:134–153.
- Notarnicola A, Lapadula G, Natuzzi D, et al. Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies. Scand J Rheumatol. 2015;44(3):224–228.
- Salomonsson S, Lundberg IE. Cytokines in idiopathic inflammatory myopathies. Autoimmunity. 2006;39(3):177–190.
- Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23–35.
- Gordon S. The macrophage: past, present and future. Eur J Immunol. 2007;37(1):S9–S17.
- Jiang T, Huang Y, Liu H, et al. Reduced miR-146a promotes REG3A expression and macrophage migration in polymyositis and dermatomyositis. Front Immunol. 2020;11:37.
- Yin Y, Li F, Shi J, et al. MiR-146a regulates inflammatory infiltration by macrophages in polymyositis/dermatomyositis by targeting TRAF6 and affecting IL-17/ICAM-1 pathway. Cell Physiol Biochem. 2016;40(3–4):486–498.
- Dalakas MC. Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am. 2002;28(4):779–798.
- Pozzobon T, Goldoni G, Viola A, et al. CXCR4 signaling in health and disease. Immunol Lett. 2016;177:6–15.
- Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol. 2000;18:217–242.
- Furusato B, Mohamed A, Uhlen M, et al. CXCR4 and cancer. Pathol Int. 2010;60(7):497–505.
- Lv J, Li L, Li W, et al. Role of the chemokine receptors CXCR3, CXCR4 and CCR7 in the intramuscular recruitment of plasmacytoid dendritic cells in dermatomyositis. J Neuroimmunol. 2018;319:142–148.
- De Paepe B, Creus KK, De Bleecker JL. Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses. Ann NY Acad Sci. 2007;1109:441–453.
- Schreier BA, Stadler HA. Perspectives of research participants, psychologist investigators, and institutional review boards. Percept Mot Skills. 1992;74(3 Pt 2):1067–1072.
- Xu X, Chen H, Lin Y, et al. MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met. Mol Cells. 2013;36(1):62–68.
- Zhang G, Liu Z, Xu H, et al. miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1. Biochem Biophys Res Commun. 2016;469(2):189–195.
- Wu S, Du X, Wu M, et al. MicroRNA-409-3p inhibits osteosarcoma cell migration and invasion by targeting catenin-δ1. Gene. 2016;584(1):83–89.
- Liu T, Zhong S, Rao F, et al. Catheter ablation restores decreased plasma miR-409-3p and miR-432 in atrial fibrillation patients. Europace. 2016;18(1):92–99.
- Liu X, Zhou F, Yang Y, et al. MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3/STAT3 signaling. Glia. 2019;67(1):101–112.
- Troyanov Y, Targoff IN, Payette MP, et al. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine. 2014;93(24):318–332.
- Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344–347.
- Zhang Z, Li H, Zhao Z, et al. Feng X: miR-146b level and variants is associated with endometriosis related macrophages phenotype and plays a pivotal role in the endometriotic pain symptom. Taiwan J Obstet Gynecol. 2019;58(3):401–408.
- Kang J, Zhang HY, Feng GD, et al. Development of an improved animal model of experimental autoimmune myositis. Int J Clin Exp Pathol. 2015;8(11):14457–14464.
- Hachisu M, Hashizume M, Kawai H, et al. Finding prodromal frailty in a community-dwelling healthy older cohort by survey of BDNF or hand grip strength classified by BMI. Aging Pathobiol Ther. 2020;2(3):155–161.
- Liu Y, Gao Y, Yang J, et al. MicroRNA-381 reduces inflammation and infiltration of macrophages in polymyositis via downregulating HMGB1. Int J Oncol. 2018;53(3):1332–1342.
- Xu X, Wei T, Zhong W, et al. IL-17 regulates the expression of major histocompatibility complex II and VEGF in DLBCL mice on tumor growth. Aging Pathobiol Ther. 2020;2(2):96–100.
- Pandya JM, Loell I, Hossain MS, et al. Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis. Arthritis Res Ther. 2016;18(1):80.
- Dalakas MC. Immunotherapy of myositis: issues, concerns and future prospects. Nat Rev Rheumatol. 2010;6(3):129–137.